Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2026-03-11 @ 6:51 AM
Study NCT ID:
NCT05227118
Status:
COMPLETED
Last Update Posted:
2024-09-25
First Post:
2022-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MK-8189 Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-27
First Submit QC Date:
None
Study First Post Date:
2022-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-15
Results First Submit QC Date:
None
Results First Post Date:
2024-09-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-13
Last Update Post Date:
2024-09-25
Last Update Post Date Type:
ACTUAL